Metamark Genetics Inc.

Company Changes AVILA , Manny To: IlluminOss Medical Inc. , CEO (October) From: OmniGuide Inc., Global VP, Sales & Mktg. Phone: 401-714-0008 CLENDENINN , Neil J., MD, PhD To: Heron Therapeu

Company Changes ALATARIS , Kostantinos, PhD To: Zosano Pharma Corp. , Pres. & COO (September) From: IRRAS AB, Exec. Chairman Phone: 510-745-1200 BARTH , Neil M., MD To: Veracyte Inc. , CMO

New At The Helm Company Changes ABUSHAKRA , Susan, MD To: Alzheon Inc. , CMO (September) From: Transition Therapeutics Inc., CMO Phone: 857-214-7242 ALATARIS , Kostantinos, PhD To: Zosano P

Device Transactions Medtech fundraising totaled $714 million in 2014’s opening quarter, a significant decrease – just over 40% – from Q4 2013’s $1.2 billion. ( See Exhibit 1. ) Exhibit 1 Q1 2014 Devic